Herbas VPB

Print
EN | LT
LT - Bispecifiniai vienvalenčiai diakūnai, kurie geba prisijungti prie CD123 ir CD3, bei jų panaudojimas
EN - BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 11/06 (2006.01)
A61P 17/02 (2006.01)
A61P 19/02 (2006.01)
A61P 35/04 (2006.01)
A61P 37/00 (2006.01)
A61P 37/08 (2006.01)
C07K 16/28 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
A61P 35/02 (2006.01)
A61P 29/00 (2006.01)
European patent
(11) Number of the document 3035965
(13) Kind of document T
(96) European patent application number 14837858.1
Date of filing the European patent application 2014-08-20
(97) Date of publication of the European application 2016-06-29
(45) Date of publication and mention of the grant of the patent 2020-11-11
(46) Date of publication of the claims translation 2021-04-12
PCT application
(86) Number PCT/US2014/051790
Date 2014-08-20
PCT application publication
(87) Number WO 2015/026892
Date 2015-02-26
Priority applications
(30) Number Date Country code
201361869510 P 2013-08-23 US
201361907749 P 2013-11-22 US
13198784 2013-12-20 EP
201461990475 P 2014-05-08 US
Inventors
(72)
BONVINI, Ezio, US
JOHNSON, Leslie S., US
HUANG, Ling, US
MOORE, Paul A., US
CHICHILI, Gurunadh Reddy, US
ALDERSON, Ralph Froman, US
Grantee
(73) MacroGenics, Inc., 9704 Medical Center Drive, Rockville, MD 20850, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Bispecifiniai vienvalenčiai diakūnai, kurie geba prisijungti prie CD123 ir CD3, bei jų panaudojimas
  BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF
Last renewal fee
Payment date Validity (years) Amount
2021-08-23 8 277.50 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2022-08-20